That high level VEGFR-1 expression is associated with poor disease outcome both in PTEN deleted and in PTEN undeleted cancers is further suggesting that a more complex dysregulation of PI3K/AKT signaling by multiple independent alterations of pathway components may have a clinically relevant additive impact. Here, FLT1 is linked to cancer.